Diamicron 30Mr Tab

Diamicron Mr 60 Mg Tablets

Description:

Diamicron MR 60 mg tablets are an oral antidiabetic prescription medicine containing the sulfonylurea agent gliclazide in a modified-release (MR) formulation. They are used to help control blood glucose levels in adults with type 2 diabetes mellitus when diet, exercise, and weight reduction alone are not sufficient. By stimulating insulin secretion from the pancreas and improving the body’s response to insulin, Diamicron MR 60 mg supports long-term blood sugar control and helps reduce the risk of diabetes-related complications when used as part of a comprehensive diabetes management plan.

Indications:

• Type 2 diabetes mellitus (non–insulin-dependent diabetes) in adults.
• Glycemic control in patients whose blood sugar is inadequately controlled with diet, physical activity, and weight loss alone.
• May be used as monotherapy or in combination with other oral antidiabetic agents or insulin, as directed by a physician.
• Helps reduce symptoms and risks associated with poorly controlled blood glucose such as excessive thirst, frequent urination, fatigue, and long-term microvascular and macrovascular complications.

Active Ingredients / Key Components:

• Gliclazide – 60 mg per modified-release tablet.
• Excipients: The full list of inactive ingredients (excipients, coating agents, stabilizers, preservatives) is not available in the provided information. Please refer to the official package leaflet for complete composition.

Dosage & Administration / How to Use:

• Diamicron MR 60 mg is for oral use only and must be taken exactly as prescribed by your doctor.
• Usual starting dose: The typical initial dose and any dose adjustments must be determined individually by the treating physician based on blood glucose response and previous antidiabetic therapy. Do not change your dose without medical advice.
• Administration: Swallow the tablet whole with a glass of water, preferably once daily with breakfast. Do not crush, chew, or split the modified-release tablet, as this may alter the release profile of the medicine.
• Take the tablet at the same time each day to maintain consistent blood levels and optimal glycemic control.
• If a dose is missed: Take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten tablet.
• Use in combination therapy: When used with other antidiabetic medicines (such as metformin, DPP-4 inhibitors, SGLT2 inhibitors, or insulin), your doctor may adjust doses and monitor blood glucose more frequently to reduce the risk of hypoglycemia.
• Diet and lifestyle: Continue to follow your prescribed diabetic diet, exercise program, and weight management plan while taking Diamicron MR 60 mg.

Clinical Benefits:

• Helps lower and stabilize blood glucose levels in adults with type 2 diabetes mellitus.
• Stimulates insulin release from pancreatic beta cells and improves glucose tolerance, especially after meals.
• Improves tissue sensitivity to insulin, supporting better utilization of glucose by the liver and peripheral tissues.
• Modified-release formulation provides more gradual and sustained action over the day, which may help reduce fluctuations in blood sugar levels.
• When used long term as part of a comprehensive diabetes management plan, it helps reduce the risk of diabetes-related complications affecting the eyes, kidneys, nerves, and cardiovascular system.

Warnings & Contraindications:

• Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, pre-coma or diabetic coma.
• Contraindicated in severe renal or severe hepatic impairment, as altered metabolism may increase the risk of hypoglycemia and adverse effects.
• Do not use if you have known hypersensitivity or allergy to gliclazide, other sulfonylureas, sulfonamides, or any component of the formulation.
• Use with caution in elderly patients, those with irregular meal patterns, malnutrition, adrenal or pituitary insufficiency, or those with mild to moderate renal or hepatic impairment, as they are at higher risk of hypoglycemia.
• Alcohol intake may potentiate the hypoglycemic effect and should be limited or avoided.
• May interact with other medications such as other antidiabetics, beta-blockers, ACE inhibitors, NSAIDs, certain antibiotics, and anticoagulants. Inform your doctor about all medicines and supplements you are taking.
• Driving and operating machinery: Hypoglycemia can impair concentration and reaction time. Use caution when driving or operating machines, especially at the start of treatment or when doses are changed.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as liver disease, kidney disease, adrenal or pituitary disorders, or cardiovascular disease.
• Not intended to diagnose, treat, cure, or prevent any disease without appropriate medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects: Hypoglycemia (low blood sugar) with symptoms such as sweating, tremor, hunger, palpitations, headache, dizziness, fatigue, irritability, or confusion. Mild hypoglycemia is usually corrected by taking fast-acting carbohydrates (e.g., glucose tablets, sugary drink).
• Gastrointestinal effects: Nausea, vomiting, abdominal pain, indigestion, or diarrhea may occur in some patients.
• Allergic reactions: Skin rash, itching, redness, or urticaria. Rarely, more severe reactions such as angioedema may occur.
• Hematologic effects (rare): Changes in blood cell counts such as anemia, leukopenia, or thrombocytopenia have been reported with sulfonylureas.
• Severe hypoglycemia: Prolonged or severe low blood sugar may lead to loss of consciousness, seizures, or coma and requires urgent medical attention.
• If you experience severe, persistent, or unusual symptoms, stop taking the medicine and seek medical advice immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the packaging. Do not store above the temperature recommended in the official leaflet (specific temperature information is not available here; please refer to the product pack).

Specifications:

• Product type: Prescription oral antidiabetic medicine.
• Active ingredient: Gliclazide 60 mg per modified-release tablet.
• Form: Tablet (modified-release).
• Intended use: Adults with type 2 diabetes mellitus.
• Pack size: Exact tablet count per pack is not available in the provided information; please refer to the product packaging.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.